Clinical Trial Update: A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia

View source ↗

Summary

This completed real-world study evaluated adherence, treatment patterns, patient characteristics, and effectiveness of Inclisiran in patients with atherosclerot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• LEQVIO (inclisiran)

Snippet

Sponsor: Novartis | Conditions: Atherosclerotic Cardiovascular Disease, Hypercholesterolemia | Status: COMPLETED